(Total Views: 232)
Posted On: 11/10/2021 5:47:11 PM
Post# of 48
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
Another TGF-beta acquisition- bode well for $OTLC/ OT-101 TGF beta inhibitor
https://www.thepharmaletter.com/article/agoma...-origo-buy
“TGF-β is a validated pathway known to be a master regulator of fibrogenesis. Leveraging their advanced small molecule expertise, the Origo team has done an amazing job developing organ-restricted TGF-β approaches, which circumvent toxicity concerns associated with systemic TGF-β blockade.”
https://www.thepharmaletter.com/article/agoma...-origo-buy
“TGF-β is a validated pathway known to be a master regulator of fibrogenesis. Leveraging their advanced small molecule expertise, the Origo team has done an amazing job developing organ-restricted TGF-β approaches, which circumvent toxicity concerns associated with systemic TGF-β blockade.”
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)